Sears Capital Management, Inc. is a venture investment firm specializing in the life sciences. Since its founding in 1994, Sears Capital Management and its affiliated funds have provided seed capital and early stage financing for life science companies and startups.

Sears Capital Management's investment areas are pharmaceuticals and medical devices. In addition, Sears Capital Management manages and executes the liquidation of shares in portfolio companies that have gone public.

We take pride that the companies we have helped found, seed with capital, and backed over the years have brought life-saving and improving therapies to patients around the world.


Sears Capital Management invests in life science ventures that have three basic elements:

  1. An entrepreneur capable of assembling a team that can execute development and commercialization of a technology/product portfolio. If a management team already exists, that collectively it has the capabilities to successfully execute.
  2. Proprietary and differential technology and/or products
  3. Defined path to commercialization with well-understood markets and customer needs

Sears Capital Management investments to date have been sourced exclusively through personal industry contacts and backed by extensive due diligence. We do not accept investment proposals from investment bankers, financial advisors or agents.

As an active investor, Sears Capital Management assists portfolio companies with a range of business and strategic needs, including financing, corporate partnering, and management recruiting.

The focus of our board representation is to increase shareholder value. We believe in rewarding management performance and taking action, including replacing management, if the required performance is not achieved.